Pharma News

Perrigo expands global ambitions with Elan buy

Home/Pharma News | Posted 16/08/2013

US-based generics maker Perrigo Company (Perrigo) announced on 29 July 2013 that it would acquire Irish biotechnology company Elan Corporation (Elan) for US$8.6 billion.

Pfizer prepares to split off generics business

Home/Pharma News | Posted 09/08/2013

Pfizer, the world’s largest research-based pharmaceutical company, has announced plans to split off its generics drug business into a separate commercial operation. News of the plans came as the company reported its second quarter 2013 results at the end of July.

Aspen makes deals with Merck and GSK

Home/Pharma News | Posted 09/08/2013

Generics manufacturer Aspen Pharmacare Holdings (Aspen) is expanding its brand-name business, first signing a deal with Pharma giant Merck, and then offering to buy two brand-name heart medications from GlaxoSmithKline (GSK).

CFR pharma expands global ambitions with Adcock bid

Home/Pharma News | Posted 02/08/2013

Chile-based CFR Pharmaceuticals (CFR) has plans to become a global drugmaker. In its latest efforts it has made a US$1.3 billion cash-and-share offer for South Africa’s second-largest generics drugmaker Adcock Ingram (Adcock).

UK plans to cut drug prices by up to 20%

Home/Pharma News | Posted 05/07/2013

The UK’s Department of Health (DoH) has launched a consultation to strengthen the statutory pharmaceutical pricing scheme, which covers the prices the National Health Service (NHS) pays for brand-name drugs not covered by the voluntary Pharmaceutical Price Regulation Scheme (PPRS). The consultation is seeking views on a price cut on drug prices of between 10% and 20% to ensure the NHS continues to get good value for money.

Viagra generics hit the market in Europe

Home/Pharma News | Posted 28/06/2013

The patent on Pfizer’s blockbuster erectile dysfunction drug Viagra (sildenafil) expired on 21 June 2013 in the UK, along with several other European countries.

Nigeria needs to combat fake drugs and ageing facilities

Home/Pharma News | Posted 14/06/2013

Nigeria has ageing drug-manufacturing facilities and a problem with imports of fake drugs, according to Mr Olakunle Ekundayo, Group Managing Director, Drugfield Pharmaceuticals.

Sun Pharma looking to buy Sweden’s Meda

Home/Pharma News | Posted 07/06/2013

India-based Sun Pharmaceutical Industries (Sun Pharma) is reportedly in talks to acquire Swedish drugmaker Meda for US$5–6 billion.

Actavis makes definitive agreement with Warner Chilcott

Home/Pharma News | Posted 24/05/2013

US generic drugmaker Actavis (formerly Watson) and Irish drugmaker Warner Chilcott announced on 20 May 2013 that the two companies had entered into a definitive agreement under which Actavis will acquire Warner Chilcott in a stock-for-stock transaction valued at approximately US$8.5 billion.

Actavis in discussions to buy Warner Chilcott

Home/Pharma News | Posted 17/05/2013

US generics maker Actavis (formerly Watson) confirmed on 14 May 2013 that the company had entered into discussions to buy Irish drugmaker Warner Chilcott.

Valeant deal to acquire Actavis on hold

Home/Pharma News | Posted 10/05/2013

Drugmaker Valeant Pharmaceuticals International (Valeant) was in talks to acquire generics manufacturer Actavis for more than US$13 billion, in what would rank as one of the biggest healthcare deals this year. However, reports are that the deal is now on hold.

UK accuses GSK of delaying generics

Home/Pharma News | Posted 29/04/2013

The UK’s competition watchdog is accusing GlaxoSmithKline (GSK) of delaying the entry of generics to its antidepressant drug Seroxat (paroxetine) by paying rival companies to stay off the market.

Generics drugmakers should be held responsible for injuries

Home/Pharma News | Posted 29/03/2013

In the long saga of generics pre-emption, The New York Times is adding its opinion to the argument of whether generics makers are liable for injuries caused by their products. The newspaper believes that ‘manufacturers should bear responsibility for making sure their drugs are safe and effective’ and is urging US Congress to amend laws to allow patients to sue generics manufacturers.

Greece and Syria facing severe drug shortages

Home/Pharma News | Posted 22/03/2013

Greece and Syria are both facing severe shortages in essential medicines, but for very different reasons.

Drugmakers accused of stopping shipments to Greece

Home/Pharma News | Posted 08/03/2013

Greece is facing a severe drug shortage in more than 200 drugs. The worrying situation is being blamed on drugmakers that have stopped shipping their products to the country due to debts or fear of parallel trade.

Drug shortages linked to quality control costs

Home/Pharma News | Posted 22/02/2013

Lack of reward for manufacturing quality is forcing manufacturers of sterile injectable generics to reduce investments into quality system and is leading to drug shortages, according to FDA officials [1].

Sun Pharma ends attempt to gain full control of Taro

Home/Pharma News | Posted 22/02/2013

Sun Pharmaceutical Industries (Sun Pharma) announced on 8 February 2013 that it had given up on its effort to buy the remaining stock of Taro Pharmaceutical Industries (Taro) for about US$685 million after Taro shareholders held out for a higher price.

EC accuses J&J and Novartis of delaying generic fentanyl

Home/Pharma News | Posted 15/02/2013

On 31 January 2013 the European Commission (EC) sent a statement of objections, to US-based Johnson & Johnson (J&J) and Switzerland-based Novartis accusing them of delayed entry of a generic painkiller.

Generic Doxil approval may help alleviate drug shortages

Home/Pharma News | Posted 08/02/2013

FDA announced on 4 February 2013 that the agency had approved the first generic version of the cancer drug Doxil (doxorubicin hydrochloride liposome injection).

Generics and biosimilars Initiative

News

Research

General